Comprehensive proteomic profiling of bevacizumab-resistant glioblastoma multiforme

K. L. Kaufman; L. Ly; M. McKay; D. M. Mallawaaratchy; S. Mactier; B. Crossett; M. Molloy; M. E. Buckland; K. L. McDonald; R. I. Christopherson

doi:10.1093/neuonc/nou174.376

Comprehensive proteomic profiling of bevacizumab-resistant glioblastoma multiforme

K. L. Kaufman, L. Ly, M. McKay, D. M. Mallawaaratchy, S. Mactier, B. Crossett, M. Molloy, M. E. Buckland, K. L. McDonald, R. I. Christopherson

Research output: Contribution to journal › Meeting abstract

Original language	English
Article number	ii98
Pages (from-to)	1
Number of pages	1
Journal	Neuro-Oncology
Volume	16
Issue number	Supplement 2
DOIs	https://doi.org/10.1093/neuonc/nou174.376
Publication status	Published - Sept 2014
Event	11th Congress of the European-Association-of-Neuro-Oncology - Turin, Italy Duration: 9 Oct 2014 → 12 Oct 2014

Access to Document

10.1093/neuonc/nou174.376

Cite this

@article{64ee45ffee324342ab4d7b1a63d5ec99,

title = "Comprehensive proteomic profiling of bevacizumab-resistant glioblastoma multiforme",

author = "Kaufman, {K. L.} and L. Ly and M. McKay and Mallawaaratchy, {D. M.} and S. Mactier and B. Crossett and M. Molloy and Buckland, {M. E.} and McDonald, {K. L.} and Christopherson, {R. I.}",

year = "2014",

month = sep,

doi = "10.1093/neuonc/nou174.376",

language = "English",

volume = "16",

pages = "1",

journal = "Neuro-Oncology",

issn = "1522-8517",

publisher = "OXFORD UNIV PRESS INC",

number = "Supplement 2",

note = "11th Congress of the European-Association-of-Neuro-Oncology ; Conference date: 09-10-2014 Through 12-10-2014",

}

TY - JOUR

T1 - Comprehensive proteomic profiling of bevacizumab-resistant glioblastoma multiforme

AU - Kaufman, K. L.

AU - Ly, L.

AU - McKay, M.

AU - Mallawaaratchy, D. M.

AU - Mactier, S.

AU - Crossett, B.

AU - Molloy, M.

AU - Buckland, M. E.

AU - McDonald, K. L.

AU - Christopherson, R. I.

PY - 2014/9

Y1 - 2014/9

U2 - 10.1093/neuonc/nou174.376

DO - 10.1093/neuonc/nou174.376

M3 - Meeting abstract

SN - 1522-8517

VL - 16

SP - 1

JO - Neuro-Oncology

JF - Neuro-Oncology

IS - Supplement 2

M1 - ii98

T2 - 11th Congress of the European-Association-of-Neuro-Oncology

Y2 - 9 October 2014 through 12 October 2014

ER -